z-logo
open-access-imgOpen Access
Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade
Author(s) -
Chensu Wang,
Ang Cui,
Maurice Bukenya,
Aereas Aung,
Dikshant Pradhan,
Charles A. Whittaker,
Yash Agarwal,
Ayush Thomas,
Simon Liang,
Parastoo Amlashi,
Heikyung Suh,
Stefani Spranger,
Nir Hacohen,
Darrell J. Irvine
Publication year - 2021
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.110021
Subject(s) - reprogramming , immune checkpoint , innate immune system , cancer research , blockade , immune system , immunology , biology , immunotherapy , antibody , cell , receptor , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom